Catalyst Wire Dossier Catalyst Wire Dossier

Dextromethorphan and bupropion sustained-release tablets

· CSPC Ouyi Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dextromethorphan and bupropion sustained-release tablets, covering 2025-05-06 to 2025-05-06. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive Disorder [Phase 3]

See pricing